The aims of this study were to investigate the association of plasma biomarkers of pathological mechanisms involved in neurodegeneration (amyloid, beta, Tau, inflammation and glia activation) with biomarkers of brain atrophy and vascular pathology in DLB. This evidence concerns the gene MAPT and Lewy body dementia.